The prognosis for rhabdomyosarcoma has improved greatly in recent decades, with over 70% of patients surviving for five years after diagnosis. Nevertheless, some FN-RMS patients with a rare Leu122Arg mutation in MYOD1 gene have a very poor outcome.
Embryonal rhabdomyosarcoma
Endodermal sinus tumor
Primitive neuroectodermal tumor
Malignant rhabdoid tumour
Immature teratoma
Germ cell tumor
Neurofibroma
Sclerosing rhabdomyosarcoma